10:55am ET
Investing
The Next Big Stock Splits After Apple
In a new research report, analysts at Credit Suisse wonder if Apple's huge seven-for-one split may start a new trend. Here are some of the companies that they think may be ripe…
BIIB Coverage Page 29
7:30am ET
Investing
After the Apple Split, Five More Bull Market Stock Splits Needed
Could stock splits be coming back in vogue? Apple finally announced a major stock split. What is amazing is that the split was so large, on a seven-for-one basis.
12:00pm ET
Health and Healthcare
Biotech Earnings Previews: Amgen, Biogen Idec, Gilead, Celgene
ThinkstockBiotech stocks took it on the chin during the sell-off. In fact, biotech stocks may have even led the sell-off of momentum stocks in a reality check. The problem is that after…
8:25am ET
Health and Healthcare
Credit Suisse Says Grit Your Teeth and Buy Biotech
In a new report, the Credit Suisse team says large cap biotech is cheaper than the S&P 500 on 2016 and 2017 numbers. Here are the top biotech names rated Outperform at…
8:20am ET
Health and Healthcare
Stifel Says Strong Earnings Will Reignite Biotech Rally
ThinkstockWhen the biotech sell-off started in late February, the stocks had been market leaders for almost four years. The staggering and intense selling knocked a quick 17% off the index and immediately…
3:37pm ET
Health and Healthcare
Biotech Giants Now Priced Like Old World Drug Stocks
Most investors buying Big Pharma stocks these days are buying them for dividends and somewhat of a defensive position against stock market volatility. Investors who are buying biotechs generally are looking for…
8:20am ET
Health and Healthcare
Large Cap Biotechs Trading With Only Big Pharma P/E Ratios
In a new report from RBC, its analysts say that biotech stocks trading at some of the lowest forward multiples in years are very attractive for many investors. Here are the top…
12:50pm ET
Health and Healthcare
Teva’s Latest Victory in Effort to Protect Key Patents
Teva Pharmaceutical shares reached a new multiyear high Monday after the U.S. Supreme Court agreed to hear its appeal to revive a patent on its top-selling multiple-sclerosis drug.
8:55am ET
Health and Healthcare
Morgan Stanley Starts Mixed Coverage on Top Biotech Stocks
courtesy of Morgan StanleyLike many of its Wall Street peers, the brutal sell-off in the biotechnology space has Morgan Stanley taking a closer look at the top names. The firm initiated coverage…
8:40am ET
Investing
Top Analyst Upgrades and Downgrades: Apple, BlackBerry, Chesapeake, Citigroup, King Digital and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Thursday, March 27, 2014. They include Apple, BlackBerry, Chesapeake Energy, Citigroup and King Digital.
9:55am ET
Health and Healthcare
Top Biotechnology Stocks On Sale Again
For the second time in less than a month, the biotechnology sector got whacked when once again, chatter coming from the halls of Congress hit the sector hard. This may be a…
8:45am ET
Health and Healthcare
Catalysts That Could Push Top Biotech Stocks Even Higher
Many bears on Wall Street say that biotech stocks are overvalued, but many trade in line with historical valuations. In a new research report, Cowen highlights upcoming catalysts that could send some…
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: Biogen, Exxon, MarkWest, Yum! and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms in Thursday, March 6, 2014. The include Biogen Idec, Exxon Mobil, MarkWest Energy and Yum! Brands.
8:50am ET
Health and Healthcare
Merrill Lynch’s Top Health Care Stocks to Buy Now
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to outperform for the balance of 2014. Here are some of the top…
7:00am ET
Health and Healthcare
Short Sellers Return to Biotech Stocks
After largely shying away in the previous period, short sellers returned to many of the leading biotech and emerging pharmaceutical stocks in early February. The largest upswings happened to BioMarin Pharmaceutical and…